Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia? [electronic resource]
Producer: 20130708Description: 1454-5 p. digitalISSN:- 1592-8721
No physical items for this record
Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment
There are no comments on this title.
Log in to your account to post a comment.